Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    GSK

    NYSE: GSK · Real-Time Price · USD
    40.48
    -0.38 (-0.93%)
    At close: Jun 16, 2025, 3:59 PM
    40.63
    0.36%
    After-hours: Jun 16, 2025, 05:52 PM EDT

    GSK Statistics

    Share Statistics

    GSK has 2.03B shares outstanding. The number of shares has increased by -0.25% in one year.

    Shares Outstanding

    n/a
    		 2.03B

    Shares Change (YoY)

    n/a
    		 -0.25%

    Shares Change (QoQ)

    n/a
    		 -0.31%

    Owned by Institutions (%)

    n/a
    		 8.36%

    Shares Floating

    n/a
    		 3.95B

    Failed to Deliver (FTD) Shares

    n/a
    		 48,949

    FTD / Avg. Volume

    n/a
    		 0.93%

    Short Selling Information

    The latest short interest is 16.67M, so 0.82% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 16.67M

    Short % of Shares Out

    n/a
    		 0.82%

    Short % of Float

    n/a
    		 0.82%

    Short Ratio (days to cover)

    n/a
    		 3.58

    Valuation Ratios

    The PE ratio is 21.39 and the forward PE ratio is 10.7. GSK's PEG ratio is -0.44.

    PE Ratio

    n/a
    		 21.39

    Forward PE

    n/a
    		 10.7

    PS Ratio

    n/a
    		 1.76

    Forward PS

    n/a
    		 1.7

    PB Ratio

    n/a
    		 4.03

    P/FCF Ratio

    n/a
    		 15.42

    PEG Ratio

    n/a
    		 -0.44
    Financial Ratio History

    Enterprise Valuation

    GSK has an Enterprise Value (EV) of 123.47B.

    EV / Sales

    n/a
    		 3.94

    EV / EBITDA

    n/a
    		 18.52

    EV / EBIT

    n/a
    		 18.84

    EV / FCF

    n/a
    		 34.57

    Financial Position

    The company has a current ratio of 0.78, with a Debt / Equity ratio of 1.24.

    Current Ratio

    n/a
    		 0.78

    Quick Ratio

    n/a
    		 0.52

    Debt / Equity

    n/a
    		 1.24

    Debt / EBITDA

    n/a
    		 2.55

    Debt / FCF

    n/a
    		 4.76

    Interest Coverage

    n/a
    		 6.28

    Financial Efficiency

    Return on Equity is 18.84% and Return on Invested Capital is 8.51%.

    Return on Equity

    n/a
    		 18.84%

    Return on Assets

    n/a
    		 4.33%

    Return on Invested Capital

    n/a
    		 8.51%

    Revenue Per Employee

    n/a
    		 $457,182.82

    Profits Per Employee

    n/a
    		 $37,520.58

    Employee Count

    n/a
    		 68,629

    Asset Turnover

    n/a
    		 0.53

    Inventory Turnover

    n/a
    		 1.6

    Taxes

    Income Tax

    n/a
    		 526M

    Effective Tax Rate

    n/a
    		 15.13%

    Stock Price Statistics

    The stock price has increased by 0.49% in the last 52 weeks. The beta is 0.27, so GSK's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.27

    52-Week Price Change

    n/a
    		 0.49%

    50-Day Moving Average

    n/a
    		 38.12

    200-Day Moving Average

    n/a
    		 37.53

    Relative Strength Index (RSI)

    n/a
    		 56.4

    Average Volume (20 Days)

    n/a
    		 5,289,726

    Income Statement

    In the last 12 months, GSK had revenue of 31.38B and earned 2.58B in profits. Earnings per share was 1.26.

    Revenue

    n/a
    		 31.38B

    Gross Profit

    n/a
    		 22.33B

    Operating Income

    n/a
    		 4.02B

    Net Income

    n/a
    		 2.58B

    EBITDA

    n/a
    		 6.67B

    EBIT

    n/a
    		 4.12B

    Earnings Per Share (EPS)

    n/a
    		 1.26
    Full Income Statement

    Balance Sheet

    The company has 3.69B in cash and 16.99B in debt, giving a net cash position of -13.29B.

    Cash & Cash Equivalents

    n/a
    		 3.69B

    Total Debt

    n/a
    		 16.99B

    Net Cash

    n/a
    		 -13.29B

    Retained Earnings

    n/a
    		 7.8B

    Total Assets

    n/a
    		 60.7B

    Working Capital

    n/a
    		 -2.75B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 6.55B and capital expenditures -2.98B, giving a free cash flow of 3.57B.

    Operating Cash Flow

    n/a
    		 6.55B

    Capital Expenditures

    n/a
    		 -2.98B

    Free Cash Flow

    n/a
    		 3.57B

    FCF Per Share

    n/a
    		 0.88
    Full Cash Flow Statement

    Margins

    Gross margin is 71.16%, with operating and profit margins of 12.82% and 8.21%.

    Gross Margin

    n/a
    		 71.16%

    Operating Margin

    n/a
    		 12.82%

    Pretax Margin

    n/a
    		 11.08%

    Profit Margin

    n/a
    		 8.21%

    EBITDA Margin

    n/a
    		 21.25%

    EBIT Margin

    n/a
    		 12.82%

    FCF Margin

    n/a
    		 11.38%

    Dividends & Yields

    GSK pays an annual dividend of $1.98, which amounts to a dividend yield of 4.26%.

    Dividend Per Share

    n/a
    		 $1.98

    Dividend Yield

    n/a
    		 4.26%

    Dividend Growth (YoY)

    n/a
    		 -1.33%

    Payout Ratio

    n/a
    		 96.15%

    Earnings Yield

    n/a
    		 4.67%

    FCF Yield

    n/a
    		 3.24%
    Dividend Details

    Analyst Forecast

    The average price target for GSK is $47, which is 15.1% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $47

    Price Target Difference

    n/a
    		 15.1%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $6.3

    Lynch Upside

    n/a
    		 -84.58%

    Graham Number

    n/a
    		 6.9

    Graham Upside

    n/a
    		 -83.11%

    Stock Splits

    The last stock split was on Jul 22, 2022. It was a forward split with a ratio of 613:500.

    Last Split Date

    n/a
    		 Jul 22, 2022

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 613:500

    Scores

    Altman Z-Score

    n/a
    		 1.96

    Piotroski F-Score

    n/a
    		 8

    Add to Watchlist